Exelixis
EXEL
31,52 €
Share price
-5.75%
Change (1 day)
46.44%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
We have found no stock splits for this company